MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

DBS programming requirements and longevity

M. Tagliati, E. Karst (Los Angeles, CA, USA)

Meeting: 2016 International Congress

Abstract Number: 93

Keywords: Deep brain stimulation (DBS), Implanted pulse generators(IPG)

Session Information

Date: Monday, June 20, 2016

Session Title: Surgical therapy: Parkinson's disease

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: Determine need for programming for contemporary DBS systems, and the rate of explant, revision, or replacement.

Background: DBS provides relief for motor symptoms of Parkinson’s disease (PD), Essential Tremor (ET) and dystonia. Constant-voltage systems traditionally used for DBS may require programming changes in the years after implant. Usage as well as any time-dependent variations in coupling efficiency may also have an impact on realized device longevity.

Methods: This analysis used the Truven Health MarketScan dataset of all medical claims for patients covered by private or Medicare supplemental insurance. Patients were included if there was a DBS implant from April 2009-March 2012 and at least 1 year of prior enrollment without DBS. Exclusion criteria were a primary diagnosis other than PD, ET or dystonia, or a lead for any type of neuromodulation other than DBS. Patients were evaluated for pulse generator analysis and additional programming each year after implant. Kaplan-Meier analysis was used to determine freedom from explant, revision, or replacement.

Results: There were 1799 patients with de novo DBS implants (age 62±13 years, 66% male, 44% Medicare), of whom 1315 had PD (73%), 379 had ET (21%), and 105 had dystonia (6%). Longevity for DBS systems at 3 years (see Figure) was 42% for dystonia, 59% for ET, and 60% for PD (log-rank P = 0.88). In the 1187 patients with a full year of follow-up including visits for DBS, the year after implant averaged 4.6±3.8 programming visits and 0.7±1.0 additional visits for analysis without programming. The largest number of programming visits for any patient was 35. For 527 patients with 2 years of follow-up, there were 2.4±2.5 (maximum 19) programming sessions in the second year after implant. For patients with over 2 years of follow-up, there were an additional 2.2±2.3 (maximum 17) programming visits more than 2 years after implant. Nearly 76% (988 of 1308) of all DBS follow-up visits beyond 2 years after implant included a billing code for programming the DBS system.

Conclusions: The predominantly constant-voltage DBS systems implanted over this time period require several programming visits each year in the years after implant. Future studies should determine if real-world programming requirements differ for constant-current vs. constant-voltage DBS, and whether programming frequency has an effect on longevity.

To cite this abstract in AMA style:

M. Tagliati, E. Karst. DBS programming requirements and longevity [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/dbs-programming-requirements-and-longevity/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/dbs-programming-requirements-and-longevity/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley